Skip to content
★ Sign in to follow
RE
Total declarations
9
Company
1
▲ Purchases (1 ops.)
€33k
▼ Sales (1 ops.)
€16k

Latest filing published 21 Mar 2014 for Cumberland Pharmaceuticals INC, €3,323.

Insider track record

Disclosed buys
1
Disclosed sells
1
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Robert Edwards: trading record in brief

Robert Edwards is a declared insider of Cumberland Pharmaceuticals Inc, with filings sourced from SEC (Form 4). In total, 9 filings cover trades dated from 25 May 2010 to 21 March 2014.

In open-market terms, that means 1 purchase worth €33k on one side and 1 sale worth €16k on the other. Netting one side against the other leaves €17k of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 4 share grants and 3 option exercises.

On 21 March 2014 came the latest disclosure, a share grant for €3,323 in Cumberland Pharmaceuticals Inc. The latest purchase dates back some time: it was published 6,011 days ago, on 26 May 2010. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Robert Edwards

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total

8 of 8 declarations